MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Gossamer Bio, Inc. Common Stock

GOSS

#3275
Gossamer Bio, Inc. Common Stock
0.42
+7.69%
Sector:
Base:
Profit Currency:
Daily Range
0.42
0.43
Year Range
0.33
3.87
Daily Change
+7.69%
Monthly Change
-84.33%
6 month change
-83.00%
Year Change
-63.16%
Previous Close
0.39
Open
0.42
Bid
Ask
Low
0.42
High
0.43
Volume
101
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. GOSS
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Zacks Zacks
NTLA GOSS
2 days ago, 17:15
Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates
TipRanks TipRanks
XBI GOSS IVVD RGNX MRNA
2026.02.24
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Zacks Zacks
ARVN GOSS
2026.02.24
Arvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates
Investing Investing
GOSS
2026.02.24
Gossamer Bio stock downgraded by Wedbush on trial results
Investing Investing
GOSS
2026.02.24
Barclays cuts Gossamer Bio stock rating on trial results
Investing Investing
GOSS
2026.02.24
Leerink cuts Gossamer Bio stock rating on trial miss
Investing Investing
PG WMT MCD IBM AXP
2026.02.23
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%
Investing Investing
C LLY WFC SCL TNDM
2026.02.23
Tesla, Oracle among market cap stock movers on Monday
Investing Investing
C JPM-PL LLY ORCL EXPE
2026.02.23
American Express, Oracle among market cap stock movers on Monday
Investing Investing
GOSS
2026.02.23
Gossamer Bio stock tumbles 80% on trial miss
Investing Investing
GOSS
2026.02.23
Gossamer Bio’s seralutinib misses primary endpoint in PAH trial
Benzinga Benzinga
GOSS
2026.02.23
Gossamer Bio Plans FDA Talks After Narrow Miss In Key Pivotal Study, Stock Sinks - Gossamer Bio (NASDAQ:GOSS)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd